Top Stories
-
Columbia researchers are uncovering potential new therapies to counter the changing identities of cancer cells.
Topic
-
Columbia cancer researcher Cory Abate-Shen has been elected to the National Academy of Sciences, one of science’s highest honors.
Topic
-
A new Columbia study shows that increased screening for Lynch Syndrome—an inherited condition linked to several types of cancer—could reduce deaths from colon cancer in at-risk persons by nearly 80%.
Topic
-
Columbia researchers have developed a technique that analyzes RNA and DNA within several thousands of individual tumor cells and could help doctors find the best treatment for a patient's cancer.
Topic
Latest News
- September 27, 2024
On Sunday, Oct. 6, cancer survivors, researchers, and physicians will cycle through the Hudson Valley to help Columbia solve cancer.
Topic
- September 25, 2024
Combining a diabetes drug with a cancer drug not only kills aggressive bladder cancer cells in mice, but also turns remaining malignant cells into a more benign state.
Topic
- September 6, 2024
Lewis Silverman, the new director of pediatric hematology, oncology, and stem cell transplantation, is working to minimize the aftereffects of treatment to ensure the highest quality cure possible.
Topic
- August 29, 2024
In a mouse model of breast cancer, mice fed a ketogenic diet experienced significantly more lung metastases compared to those on a control diet.
Topic
- August 29, 2024
Columbia researcher Jasmine McDonald, who studies factors that affect the risk of developing breast cancer, discusses what is known about breastfeeding's protective influence on maternal health.
Topic
- August 29, 2024
Columbia dermatologist Larisa Geskin discusses the potential dangers of the anti-sunscreen movement and how to protect yourself against the sun's harsh UV rays.
Topic
- August 20, 2024
Human embryos often fail to cope with high levels of replication stress early in development. Their failure not only impairs fertility treatment but may have long-ranging impacts on our health.
Topic
- August 14, 2024
PARP inhibitors have improved survival of breast cancer patients with BRCA1/2 mutations, but the cancer eventually returns. A Columbia study has now identified a drug that may prevent that relapse.
Topic
- August 9, 2024
Four Columbia researchers were awarded pilot grants—made possible by proceeds from Velocity, Columbia’s annual cycling fundraiser—to support their early-stage cancer research.
Topic
- July 19, 2024
Pathologists Dan Green and Stephen Lagana explain their jobs, describe their training, and share the most fascinating cases of their careers.
Topic
